CoChat

AURKA is one of the downstream targets of MAPK1/ERK2 in pancreatic cancer

Furukawa, T, Kanai, N, Shiwaku, H O, Soga, N, Uehara, A, Horii, A · 2006 · Oncogene

The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.

Abstract

DUSP6/MKP-3, a specific inhibitor of MAPK1/ERK2, frequently loses its expression in primary pancreatic cancer tissues. This evidence suggests that constitutive activation of MAPK1 synergistically induced by frequent mutation of KRAS2 and the loss of function of DUSP6 plays key roles in pancreatic carcinogenesis and progression. By profiling of gene expressions associated with downregulation of MAPK1 induced by exogenous overexpression of DUSP6 in pancreatic cancer cells, we found that AURKA/STK15, the gene encoding Aurora-A kinase, which plays key roles in cellular mitosis, was among the downregulated genes along with its related genes, which included AURKB, TPX2 and CENPA. An association of expression and promoter activity of AURKA with MAPK activity was verified. Knockdown of ETS2 resulted in a reduction of AURKA expression. These results indicate that AURKA is a direct target of the MAPK pathway and that its overexpression in pancreatic cancer is induced by hyperactivation of the pathway, at least via ETS2.

Overview

Integrity signals

Registry

Crossref · 10.1038/sj.onc.1209494

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 53 references

Cited by

See all 136

Metadata

Authors
Furukawa, T., Kanai, N., Shiwaku, H. O., Soga, N., Uehara, A., & Horii, A.
Affiliations
  • Tokyo Women's Medical University (JP)
  • Tohoku University (JP)
Corresponding author
Furukawa, T
Venue
Oncogene
Published
2006-03-13
Volume
25
Issue
35
Pages
4831-4839
ISSN
  • 0950-9232 (ISSN-L)
  • 1476-5594
OpenAlex
W2048245178
Cited by
135
References
50
Citations by year
2026: 1 · 2025: 8 · 2024: 6 · 2023: 9 · 2022: 10 · 2021: 9 · 2020: 6 · 2019: 5 · 2018: 8 · 2017: 4 · 2016: 8 · 2015: 4 · 2014: 8 · 2013: 4 · 2012: 6
FWCI
4.16
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Oncogene (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Pancreas Research Foundation of Japan
  • Foundation for Promotion of Cancer Research
Topics
  • Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
Keywords
AURKA, pancreatic cancer, KRAS mutation, ETS2, downstream target genes, mitosis, gene expression profiling, promoter activity, TPX2, CENP-A
MeSH terms
Cell Line, Cell Line, Transformed, Humans, Pancreatic Neoplasms, Gene Expression Regulation, Neoplastic, Protein Tyrosine Phosphatases, Protein Serine-Threonine Kinases, Mitogen-Activated Protein Kinase 1, Gene Expression Profiling, MAP Kinase Signaling System, Cell Line, Tumor, Dual Specificity Phosphatase 6, Aurora Kinase A, Aurora Kinase B, Aurora Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: AURKA is one of the downstream targets of MAPK1/ERK2 in pancreatic cancer. https://app.cochat.ai/papers/10.1038/sj.onc.1209494
The paper
Furukawa, T., Kanai, N., Shiwaku, H. O., Soga, N., Uehara, A., & Horii, A. (2006). AURKA is one of the downstream targets of MAPK1/ERK2 in pancreatic cancer. Oncogene. https://doi.org/10.1038/sj.onc.1209494

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.